Items where Author is "Murugesan, Ramesh P."

Group by: Item Type | No Grouping
Number of items: 2.

Sampath, Pavithra and Rajamanickam, Anuradha and Kannan, T and Natarajan, Alangudi Palaniappan and Syeed Hissar, S. and Dhanapal, Madhavan and Thangavelu, Bharathiraja and Jayabal, Lavanya and Murugesan, Ramesh P. and Ranganathan, Uma Devi and Babu, Subash and Bethunaickan, Ramalingam (2023) Plasma chemokines CXCL10 and CXCL9 as potential diagnostic markers of drug-sensitive and drug-resistant tuberculosis. Scientific Reports, 13 (1). p. 7404. ISSN Electronic: 2045-2322

Rosu, Laura and Madan, Jason J and Tomeny, Ewan M and Muniyandi, Malaisamy and Nidoi, Jasper and Girma, Mamo and Vilc, Valentina and Bindroo, Priyanka and Dhandhukiya, Rajdeep and Bayissa, Adamu K and Meressa, Daniel and Narendran, Gopalan and Solanki, Rajesh and Bhatnagar, Anuj K and Tudor, Elena and Kirenga, Bruce and Meredith, Sarah K and Nunn, Andrew J and Bronson, Gay and Rusen, I D and Squire, S Bertel and Worrall, Eve and Ahmad, Saleem and Alexandru, Sofia and Bellenger, Katharine and Bulga, Tolera G. and Cook, Claire and Crudu, Valeriu and Deborah, Bennet and Dodds, Wendy and Gebreegziabher, Belay A. and Goodall, Ruth L. and Gupta, Pritti and Gurumurthy, Meera and Langley, Ivor and Nalunjogi, Joanitah and Khan, Saleem and Krishnan, Saravanan and Kumar, Shravan and Lesosky, Maia and Macari, Mariana and Makwana, Mukesh and Murphy, Brendan and Murugesan, Ramesh P. and Patel, Vanita and Pirlog, Irina and Rauchenberger, Mary and Sanders, Karen and Singh, Ramesh and Subramani, Sangeetha and Teferi, Mekonnen and Tegegn, Netsanet A. and Velmurugan, Arun Babu and Whitney, Johanna (2022) Economic evaluation of shortened, bedaquiline-containing treatment regimens for rifampicin-resistant tuberculosis (STREAM stage 2): a within-trial analysis of a randomised controlled trial. The Lancet Global Health, 11 (2). e265-e277. ISSN 2214109X

This list was generated on Wed Nov 20 17:24:32 2024 UTC.